Ziverdo Kit is a combination pharmaceutical formulation containing Zinc acetate (50mg), Doxycycline (100mg), and Ivermectin (12mg), designed for the management of various infectious conditions. Zinc acetate plays a crucial role in immune modulation and exhibits antiviral properties by inhibiting viral replication and promoting mucosal healing. Doxycycline, a broad-spectrum tetracycline antibiotic, is effective against a wide range of bacterial pathogens by inhibiting protein synthesis, thereby preventing bacterial growth and proliferation. Ivermectin, an antiparasitic agent, is employed for its efficacy against certain parasitic infections and has demonstrated potential antiviral activity in specific contexts. The synergistic action of these components makes Ziverdo Kit suitable for adjunctive therapy in respiratory tract infections, parasitic infestations, and other infectious diseases where combined antimicrobial and antiparasitic effects are warranted. This combination should be used under medical supervision, considering patient-specific factors such as allergy history, pregnancy status, and potential drug interactions. Adverse effects may include gastrointestinal disturbances, hypersensitivity reactions, and photosensitivity. It is imperative to adhere to the prescribed dosage and duration to minimize resistance development and ensure therapeutic efficacy. Ziverdo Kit is contraindicated in patients with known hypersensitivity to any of its components.